Diagnostics
(Apr 2025)
Arrhythmic Risk Stratification in Patients with Arrhythmogenic Cardiomyopathy
Marisa Varrenti,
Eleonora Bonvicini,
Leandro Fabrizio Milillo,
Ilaria Garofani,
Marco Carbonaro,
Matteo Baroni,
Lorenzo Gigli,
Giulia Colombo,
Federica Giordano,
Raffaele Falco,
Antonio Frontera,
Roberto Menè,
Alberto Preda,
Sara Vargiu,
Patrizio Mazzone,
Fabrizio Guarracini
Affiliations
Marisa Varrenti
Electrophysiology Unit, De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy
Eleonora Bonvicini
Department of Cardiology, Santa Chiara Hospital, 38122 Trento, Italy
Leandro Fabrizio Milillo
Electrophysiology Unit, De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy
Ilaria Garofani
Electrophysiology Unit, De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy
Marco Carbonaro
Electrophysiology Unit, De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy
Matteo Baroni
Electrophysiology Unit, De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy
Lorenzo Gigli
Electrophysiology Unit, De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy
Giulia Colombo
Electrophysiology Unit, De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy
Federica Giordano
Electrophysiology Unit, De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy
Raffaele Falco
Electrophysiology Unit, De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy
Antonio Frontera
Electrophysiology Unit, De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy
Roberto Menè
Electrophysiology Unit, De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy
Alberto Preda
Electrophysiology Unit, De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy
Sara Vargiu
Electrophysiology Unit, De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy
Patrizio Mazzone
Electrophysiology Unit, De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy
Fabrizio Guarracini
Electrophysiology Unit, De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy
DOI
https://doi.org/10.3390/diagnostics15091149
Journal volume & issue
Vol. 15,
no. 9
p.
1149
Abstract
Read online
Arrhythmogenic cardiomyopathy is a heart disease in which the heart muscle is replaced by scar tissue. This is the main substrate for the development of malignant ventricular arrhythmias. Sudden cardiac death is the most common manifestation and can often be the first sign of the disease, especially in young people. Correct stratification of arrhythmic risk is essential for the management of these patients but remains a challenge for the clinical cardiologist. In this context, the aim of our work was to review the literature and to analyse the most important studies and new developments with regard to the stratification of the risk of arrhythmia in patients suffering from arrhythmogenic cardiopathy.
Keywords
WeChat QR code
Close